Moreover, it is known that, in addition to the above-described mutually exclusive driver mutations, secondary mutations in the TERT promoter and TP53 genes may identify thyroid cancers with a higher risk of tumor recurrence and disease-specific mortality [17,30,31,32]. This evidence concerns the gene TERT and thyroid gland carcinoma.